Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR52E6 Inhibitors

OR52E6 is a member of the olfactory receptor (OR) family, a class of genes involved in the detection of volatile chemicals in the environment, which plays a critical role in the sense of smell. The OR gene family represents the largest subset of G-protein-coupled receptors (GPCRs) in the human genome, with each receptor often exhibiting specificity for distinct odor molecules. OR52E6, like other olfactory receptors, is expressed in the olfactory epithelium, the specialized sensory tissue within the nasal cavity responsible for odor detection. The expression of OR52E6, as with other genes, is subject to regulation at multiple levels, from transcriptional to translational, and can be influenced by various intracellular and extracellular factors. A plethora of chemical compounds have been identified that can potentially inhibit the expression of genes such as OR52E6. These inhibitors can operate via diverse mechanisms, ranging from direct intervention in the transcription process to the disruption of protein translation and stability. For instance, chemicals that alter the epigenetic landscape, such as 5-Azacytidine and Trichostatin A, can decrease the expression of OR52E6 by modifying DNA methylation and histone acetylation patterns, respectively. These epigenetic modifications can render the gene less accessible to the transcriptional machinery, thereby reducing its expression. Other inhibitors might directly bind to the DNA of the OR52E6 gene, like Mithramycin A, which specifically intercalates into GC-rich sequences and potentially lowers transcription levels. Alternatively, post-transcriptional inhibitors, such as custom-designed siRNAs, can target OR52E6 mRNA for degradation, effectively silencing the gene. Furthermore, compounds like Cycloheximide and MG-132 can inhibit protein synthesis and degrade misfolded proteins, respectively, decreasing the stability and abundance of the OR52E6 protein. Each of these compounds represents a unique approach to downregulating gene expression, highlighting the complex regulatory networks that control the function of olfactory receptors at the molecular level.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This cytidine analog could cause hypomethylation of the OR52E6 gene promoter, leading to a decrease in its expression by altering the epigenetic state.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

As a histone deacetylase inhibitor, Trichostatin A may promote hyperacetylation of histones in the chromatin surrounding the OR52E6 gene, potentially decreasing its transcriptional activity.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This compound intercalates into DNA and can inhibit transcriptional elongation by RNA polymerase, which would result in a reduction of OR52E6 mRNA synthesis.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

By inhibiting RNA polymerase II, α-Amanitin can prevent the transcription of the OR52E6 gene, leading to a substantial decrease in its mRNA levels.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

This compound could bind preferentially to GC-rich sequences in the DNA, which may include the promoter region of OR52E6, resulting in decreased transcription.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

This flavonoid could downregulate the expression of the OR52E6 gene by inhibiting specific kinases and transcription factors that control gene expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Known to inhibit NF-kB signaling, Resveratrol may downregulate the expression of OR52E6 if its expression is under the control of NF-kB dependent pathways.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Though primarily targeting bacterial RNA polymerase, Rifampicin could also decrease the expression of OR52E6 by hindering transcription initiation in human cells under certain conditions.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

By increasing the pH within endosomes and lysosomes, Chloroquine could disrupt the cellular trafficking of the OR52E6 protein, leading to a reduction in functional receptor expression at the cell surface.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

This antibiotic blocks eukaryotic ribosomal translocation, leading to the inhibition of protein synthesis, which would include a reduction in synthesis of the OR52E6 protein.